Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-09-11 | 2021-01-14 | 124098 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125500 |
| TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125503 |
| ZADITEN | 1MG | TABLET | Resolved | 2020-11-06 | 2021-01-14 | 128010 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-12-03 | 2021-01-14 | 129515 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131069 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131090 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88222 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88225 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Actual shortage | 2020-08-20 | 2021-01-14 | 122712 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
| ACT AMLODIPINE | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-21 | 128034 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2020-11-19 | 2021-01-21 | 128632 |
| TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2020-12-17 | 2021-01-21 | 130285 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2021-01-15 | 2021-01-21 | 131688 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-12-17 | 2021-01-21 | 130291 |
| TEVA-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-01-24 | 2021-01-28 | 104374 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |